Clinical Trial Update: Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating erdosteine for nonalcoholic fatty liver disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Erdosteine (erdosteine)

Snippet

Sponsor: Tanta University | Conditions: Fatty Liver | Phase 1, Phase 2 | Status: RECRUITING